Dr. Greg Everett Gin, MD

Dr. Gin practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Gin's NPI, 1699091850, was assigned on April 13, 2010. Dr. Gin graduated from Albany Medical College in 2010. Dr. Gin holds California license A136431.

Dr. Gin's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Gin's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is UCI Health Center for Urological Care.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gin practices. Vendor and product names are available with a free account.

Urology is Dr. Gin's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Gin is board certified in urology by the American Board of Urology. Dmand AI has Dr. Gin's licenses on file in 2 states: California and New York.

Dmand AI lists bladder removal, enlarged prostate and urinary endoscopy among the conditions Dr. Gin treats.

CMS data shows 207 Medicare services from Dr. Gin across 7 procedure codes in 2024, for 100 Medicare patients. Medicare paid $16,135 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 100 Medicare patients who saw Dr. Gin in 2026. The largest group is 65 to 74, with 53 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 32% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gin's median patient age at 69, with 6% women.

In 2026, Dr. Gin wrote 169 Medicare Part D claims for 80 patients. 94% of them were for generic drugs. CMS names the drug for 95 of them, across 4 drugs with 11 or more claims each, at $708 in total drug cost. In 2023, CMS named 109 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Gin for performance year 2026, reported through an alternative payment model (APM). Dr. Gin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gin as offering telehealth.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 26 papers to Dr. Gin, published from 2014 to 2025. 2023 was the busiest year, with 4. The most frequent topics are Kidney Neoplasms, Nephrectomy and Prostate. Dr. Gin has published most often in Urol Oncol. Dr. Gin's most frequent co-authors are Edward M. Uchio, MD, Ketan K. Badani, MD and John Peter Sfakianos, MD.

Dmand AI links Dr. Gin to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Prostatic Hyperplasia, Prostatic Neoplasms and Urinary Retention.

CMS Open Payments shows 28 general payments to Dr. Gin from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 40% of the total. Intuitive Surgical, Inc. paid the most, $2,633.

Dmand AI lists 1 award for Dr. Gin, most recently Alpha Omega Alpha in 2009. Dr. Gin serves on Commission on Cancer VA Long Beach Healthcare System.

Dr. Gin graduated from Albany Medical College in 2010. Dr. Gin is a member of AUA.

Dr. Gin is in network with 12 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.